Canopy Clinical Research

13/05/2025

We are turning over a new leaf!

We are delighted to announce we have officially rebranded to Canopy Clinical Research!

This new chapter brings together our four research sites—Northern Beaches Clinical Research, Sutherland Shire Clinical Research, Wollongong Clinical Research, and Altona North Clinical Research—under one unified brand.

This change reflects who we are—a connected team with the shared vision of a world where the canopy of health embraces us all, ensuring every person has access to the care they deserve.

Get to know the Canopy community by heading to our brand-new website today: canopycr.com.au

18/11/2024

What is a medical trial, and why do people choose to participate?

Our Chief Executive Officer, Kris Barooshian, sat down with Starts at 60 to chat all things clinical trials.

If you are looking to learn more about clinical trials and how you can get involved, watch the video below.

To register for one of our studies, head to: https://northernbeachesclinicalresearch.com/studies/ #!/

Medical trials play a vital role in making medications safe. But what does it actually involve for those taking part? We chatted with Kris Barooshian, CEO of...

11/09/2024

New spots available on our RSV vaccine studies.

Northern Beaches Clinical Research is currently looking for local residents aged 60 and above to join our RSV research program.

This is your chance to give back to your community and help advance medicine.

Plus, you will be paid for your time and travel!

Call us today: 1300 637 175
https://northernbeachesclinicalresearch.com/studies/ #!/

29/07/2024

While RSV is more common in toddlers, older Australians are especially at risk of suffering from severe cases - experiencing similar symptoms and now similar rates of infection to the flu.

This year, there have been 124,000 recorded cases of RSV, signalling a 150% increase in cases from the same time in 2023.

TV and radio personality Ita Buttrose encourages Australians to be on the lookout for signs of infection in a recent 9 News segment, leading a national campaign to raise awareness about RSV.

Though an RSV vaccine for over 60s has recently been approved by the TGA, the need for further work in the area to improve accessibility and effectiveness remains a priority within the world of clinical research.

Read further about this story on the 9News website: https://www.9news.com.au/national/rsv-cases-rise-warning-older-people/9e148bf7-5804-446e-8e30-280f4a25983a

Interested in contributing to RSV research? Get in touch with us! You may be eligible to participate in a clinical trial. Visit our website at https://northernbeachesclinicalresearch.com/ and register your interest today.